POPULATION PHARMACOKINETICS OF INTRADERMAL VS. SUBCUTANEOUS INSULIN DELIVERY IN PATIENTS WITH TYPE 1 DIABETES.

被引：0
|
作者：
Yu, T. [1 ]
Sinha, M. [2 ]
Hillard, M. [2 ]
Sherwin, C. [1 ]
Russell, S. [2 ]
Spigarelli, M. [1 ]
机构：
[1] Univ Utah, Salt Lake City, UT USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-096
引用
收藏
页码：S48 / S49
页数：2
相关论文
共 50 条
  • [1] POPULATION PHARMACOKINETICS OF SUBCUTANEOUS AND INTRADERMAL GLUCAGON IN PATIENTS WITH TYPE 1 DIABETES
    Yu, T.
    Sinha, M.
    Stockmann, C.
    Hillard, M. A.
    Spigarelli, M. G.
    Russell, S. J.
    Sherwin, C. M. T.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E15 - E15
  • [2] Comparison of the Intradermal vs. Subcutaneous Delivery of Insulin and Glucagon in T1DM
    Sinha, Manasi
    Yu, Tian
    Sherwin, Catherine M. T.
    Hillard, Mallory A.
    Spigarelli, Michael G.
    Russell, Steven J.
    DIABETES, 2015, 64 : A276 - A276
  • [3] Use of the site of subcutaneous insulin for glucose determination in patients with Type 1 Diabetes.
    Regittnig, Werner
    Lindpointner, Stefan
    Korsatko, Stefan
    Koehler, Gerd
    Kaidar, Ruthy
    Yodfat, Ofer
    Koehler, Hans
    Ellmerer, Martin
    Pieber, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S22 - S22
  • [4] Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes
    Kochba, Efrat
    Levin, Yotam
    Raz, Itamar
    Cahn, Avivit
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (09) : 525 - 531
  • [5] Pharmacokinetics of oral spray insulin vs. regular insulin and lispro insulin in Type-1 diabetes
    Pozzilli, P
    Modi, P
    Manfrini, S
    Coppolino, G
    Costanza, F
    Fioriti, E
    DIABETES, 2002, 51 : A48 - A48
  • [6] Glucose concentrations at the site of subcutaneous insulin delivery in patients with type 1 diabetes
    Regittnig, W.
    Lindpointner, S.
    Korsatko, S.
    Koehler, G.
    Kaidar, R.
    Yodfat, O.
    Koehler, H.
    Ellmerer, M.
    Pieber, T. R.
    DIABETOLOGIA, 2009, 52 : S42 - S42
  • [7] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS ASSOCIATED WITH BETTER NAFLD INDICES IN PATIENTS WITH TYPE 1 DIABETES.
    Gianfrancesco, S.
    Raso, E.
    Bozzetto, L.
    Boccia, R.
    Della Pepa, G.
    Scarpelli, G.
    Petrosino, C.
    Annuzzi, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A173 - A173
  • [8] Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes
    Pettis, Ronald J.
    Hirsch, Laurence
    Kapitza, Christoph
    Nosek, Leszek
    Hoevelmann, Ulrike
    Kurth, Heinz-Joerg
    Sutter, Diane E.
    Harvey, Noel G.
    Heinemann, Lutz
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (04) : 443 - 450
  • [9] Impaired subcutaneous insulin delivery in type 2 diabetes patients
    Fryk, E.
    Olausson, J.
    Strindberg, L.
    Becattini, B.
    Mossberg, K.
    Schmelz, M.
    Brogren, H.
    Solinas, G.
    Jansson, P. -A.
    DIABETOLOGIA, 2018, 61 : S238 - S238
  • [10] Benefits of continuous subcutaneous insulin infusion in type 1 diabetes. Is there any doubt?
    Asuncion Martinez-Brocca, Maria
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (03): : 103 - 105
12345